Supplementary Figure 2 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Olivier Duclos et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Isabelle Blanc et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Isabelle Blanc et al.|Unknown|2023Cited by 0
Supplementary Table 3 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Isabelle Blanc et al.|Unknown|2023Cited by 0
Supplementary Table 1 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Isabelle Blanc et al.|Unknown|2023Cited by 0